ACRVVSBTAI• 6 Months (Normalized)
ACRV vs BTAI (Acrivon Therapeutics Inc. vs BioXcel Therapeutics Inc.)
Showing Closing Date Range from Mar, 21 to Sep, 17, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ACRV Performance $1.72
+7.5%
Acrivon Therapeutics Inc.
Normalized Baseline0.00%
BTAI Performance $0.07
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ACRV LEADS
+7.5%
ACRV outperforming by 7.50%
ACRVBTAI
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ACRV BTAI
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | ACRV Price | ACRV Gain (%) | BTAI Price | BTAI Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 17, 2026 | $1.72 | +7.50% | $- | - | |
| Sep 16, 2026 | $1.70 | +6.25% | $0.07 | -95.45% | +101.70% |
| Sep 15, 2026 | $1.83 | +14.37% | $0.04 | -96.96% | +111.33% |
| Sep 14, 2026 | $1.96 | +22.50% | $0.05 | -96.93% | +119.43% |
| Sep 11, 2026 | $2.00 | +25.00% | $0.05 | -96.53% | +121.53% |
| Sep 10, 2026 | $2.04 | +27.50% | $0.05 | -96.60% | +124.10% |
| Sep 09, 2026 | $1.99 | +24.37% | $0.05 | -96.80% | +121.17% |
| Sep 08, 2026 | $2.10 | +31.25% | $0.04 | -97.07% | +128.32% |
| Sep 04, 2026 | $2.13 | +33.12% | $0.07 | -94.97% | +128.09% |
| Sep 03, 2026 | $2.06 | +28.75% | $0.12 | -91.97% | +120.72% |
| Sep 02, 2026 | $2.15 | +34.37% | $0.11 | -92.72% | +127.09% |
| Sep 01, 2026 | $2.07 | +29.37% | $0.14 | -90.68% | +120.05% |
| Aug 31, 2026 | $2.09 | +30.62% | $0.16 | -88.91% | +119.53% |
| Aug 28, 2026 | $2.06 | +28.75% | $0.18 | -87.69% | +116.44% |
| Aug 27, 2026 | $2.15 | +34.37% | $0.72 | -51.09% | +85.46% |
Page 1 of 9